Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

This new catheter-based device for lymphatic drainage showed early potential to be an effective treatment option for acute decompensated heart failure.

Food and Drug Administration Commissioner Marty Makary is about to become a former FDA chief. The departure comes as no surprise since President Donald Trump OK’d a plan to fire him last week.